Home9989 • HKG
add
Shenzhen Hepalink Pharmaceutical Group Ord Shs H
Previous close
$4.45
Day range
$4.42 - $4.48
Year range
$3.02 - $5.92
Market cap
15.49B HKD
Avg Volume
2.54M
P/E ratio
-
Dividend yield
6.00%
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 1.39B | 1.53% |
Operating expense | 237.22M | 11.04% |
Net income | 156.59M | 1.00% |
Net profit margin | 11.23 | -0.53% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | 12.38% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.10B | 23.84% |
Total assets | 17.55B | -7.04% |
Total liabilities | 5.21B | -22.72% |
Total equity | 12.34B | — |
Shares outstanding | 1.47B | — |
Price to book | 0.53 | — |
Return on assets | 2.06% | — |
Return on capital | 2.27% | — |
Cash Flow
Net change in cash
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 156.59M | 1.00% |
Cash from operations | 544.03M | -38.21% |
Cash from investing | -257.55M | -297.07% |
Cash from financing | 22.60M | 103.37% |
Net change in cash | 318.64M | -7.03% |
Free cash flow | 344.07M | -44.74% |
About
Founded
Apr 21, 1998
Website
Employees
1,926